相似文献
1
Congenital disorders of glycosylation type I leads to altered processing of N-linked glycans, as well as underglycosylation.
Biochem J. 2001 Oct 15;359(Pt 2):249-54. doi: 10.1042/0264-6021:3590249.
2
The underglycosylation of plasma alpha 1-antitrypsin in congenital disorders of glycosylation type I is not random.
Glycobiology. 2003 Feb;13(2):73-85. doi: 10.1093/glycob/cwg026. Epub 2002 Dec 17.
3
Increased alpha3-fucosylation of alpha(1)-acid glycoprotein in patients with congenital disorder of glycosylation type IA (CDG-Ia).
FEBS Lett. 2001 Apr 13;494(3):232-5. doi: 10.1016/s0014-5793(01)02349-3.
4
A procedure for the analysis of site-specific and structure-specific fucosylation in alpha-1-antitrypsin.
Electrophoresis. 2016 Oct;37(20):2624-2632. doi: 10.1002/elps.201600176. Epub 2016 Sep 5.
5
Structural determination of N-linked carbohydrates by matrix-assisted laser desorption/ionization-mass spectrometry following enzymatic release within sodium dodecyl sulphate-polyacrylamide electrophoresis gels: application to species-specific glycosylation of alpha1-acid glycoprotein.
Electrophoresis. 1998 Aug;19(11):1950-9. doi: 10.1002/elps.1150191113.
6
The novel core fucosylation of Haemonchus contortus N-glycans is stage specific.
Mol Biochem Parasitol. 1998 May 15;93(1):143-7. doi: 10.1016/s0166-6851(98)00020-6.
7
Increased fucosylation and reduced branching of serum glycoprotein N-glycans in all known subtypes of congenital disorder of glycosylation I.
Glycobiology. 2003 May;13(5):367-75. doi: 10.1093/glycob/cwg040. Epub 2003 Jan 22.
8
Particle-based N-linked glycan analysis of selected proteins from biological samples using nonglycosylated binders.
J Pharm Biomed Anal. 2017 Jan 5;132:125-132. doi: 10.1016/j.jpba.2016.09.029. Epub 2016 Oct 3.
9
Characterisation of peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase A and its N-glycans.
Eur J Biochem. 1998 Feb 15;252(1):118-23. doi: 10.1046/j.1432-1327.1998.2520118.x.
10
Glycosylation of natural human neutrophil gelatinase B and neutrophil gelatinase B-associated lipocalin.
Biochemistry. 1999 Oct 19;38(42):13937-50. doi: 10.1021/bi991162e.
引用本文的文献
1
Quantitative Assessment of Core Fucosylation for Congenital Disorders of Glycosylation.
Mass Spectrom (Tokyo). 2024;13(1):A0159. doi: 10.5702/massspectrometry.A0159. Epub 2024 Nov 26.
2
Nrf2 activation attenuates genetic endoplasmic reticulum stress induced by a mutation in the phosphomannomutase 2 gene in zebrafish.
Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2758-2763. doi: 10.1073/pnas.1714056115. Epub 2018 Feb 22.
3
Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy.
PLoS One. 2016 Jul 20;11(7):e0159426. doi: 10.1371/journal.pone.0159426. eCollection 2016.
4
Global serum glycoform profiling for the investigation of dystroglycanopathies & Congenital Disorders of Glycosylation.
Mol Genet Metab Rep. 2016 Apr 17;7:55-62. doi: 10.1016/j.ymgmr.2016.03.002. eCollection 2016 Jun.
5
Glycan analysis by reversible reaction to hydrazide beads and mass spectrometry.
Anal Chem. 2012 Mar 6;84(5):2232-8. doi: 10.1021/ac202769k. Epub 2012 Feb 10.
6
Fibrotic response in fibroblasts from congenital disorders of glycosylation.
J Cell Mol Med. 2011 Aug;15(8):1788-96. doi: 10.1111/j.1582-4934.2010.01187.x.
7
Modeling a congenital disorder of glycosylation type I in C. elegans: a genome-wide RNAi screen for N-glycosylation-dependent loci.
Glycobiology. 2009 Dec;19(12):1554-62. doi: 10.1093/glycob/cwp136. Epub 2009 Sep 3.
8
Mass spectrometric analysis of glycans in elucidating the pathogenesis of CDG type IIx .
J Inherit Metab Dis. 2003;26(2-3):119-34. doi: 10.1023/a:1024476915278.
9
Komrower Lecture. Congenital disorders of glycosylation (CDG): it's all in it!
J Inherit Metab Dis. 2003;26(2-3):99-118. doi: 10.1023/a:1024431131208.
本文引用的文献
1
Analysis by matrix assisted laser desorption/ionisation-time of flight mass spectrometry of the post-translational modifications of alpha 1-antitrypsin isoforms separated by two-dimensional polyacrylamide gel electrophoresis.
Proteomics. 2001 Jun;1(6):778-86. doi: 10.1002/1615-9861(200106)1:6<778::AID-PROT778>3.0.CO;2-H.
2
Increased alpha3-fucosylation of alpha(1)-acid glycoprotein in patients with congenital disorder of glycosylation type IA (CDG-Ia).
FEBS Lett. 2001 Apr 13;494(3):232-5. doi: 10.1016/s0014-5793(01)02349-3.
3
Congenital disorders of glycosylation: genetic model systems lead the way.
Trends Cell Biol. 2001 Mar;11(3):136-41. doi: 10.1016/s0962-8924(01)01925-0.
4
Genotypes and phenotypes of patients in the UK with carbohydrate-deficient glycoprotein syndrome type 1.
J Inherit Metab Dis. 2000 Mar;23(2):162-74. doi: 10.1023/a:1005669900330.
5
Fucose in N-glycans: from plant to man.
Biochim Biophys Acta. 1999 Dec 6;1473(1):216-36. doi: 10.1016/s0304-4165(99)00181-6.
6
Expression of N-linked sialyl Le(x) determinants and O-glycans in the carbohydrate moiety of human amniotic fluid transferrin during pregnancy.
Glycobiology. 1998 Nov;8(11):1053-64. doi: 10.1093/glycob/8.11.1053.
7
Structural determination of N-linked carbohydrates by matrix-assisted laser desorption/ionization-mass spectrometry following enzymatic release within sodium dodecyl sulphate-polyacrylamide electrophoresis gels: application to species-specific glycosylation of alpha1-acid glycoprotein.
Electrophoresis. 1998 Aug;19(11):1950-9. doi: 10.1002/elps.1150191113.
8
Defective galactosylation of serum transferrin in galactosemia.
Glycobiology. 1998 Apr;8(4):351-7. doi: 10.1093/glycob/8.4.351.
9
A new alpha 1-antitrypsin mutation, Thr-Met 85, (PI Zbristol) associated with novel electrophoretic properties.
Ann Hum Genet. 1997 Sep;61(Pt 5):385-91. doi: 10.1046/j.1469-1809.1997.6150385.x.
10
Analysis of acidic oligosaccharides and glycopeptides by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Anal Chem. 1996 Sep 15;68(18):3215-23. doi: 10.1021/ac960324z.
Zotero 插件